What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to formally announce and provide access to Anthem, Inc.'s financial results for the first quarter ended March 31, 2003, through an accompanying press release (Exhibit 99).

Where can I find the detailed financial results for the first quarter of 2003?

The detailed financial results are contained within the press release dated April 30, 2003, which is filed as Exhibit 99 to this 8-K report. Investors should refer to this exhibit for specific financial data.

What are some of the key risks mentioned in the filing that could impact future performance?

The filing highlights several risks including trends in healthcare costs and utilization rates, the ability to secure sufficient premium rate increases, competitor pricing, increased government regulation of health benefits, significant acquisitions or divestitures by competitors, new prescription drugs and technology, financial strength rating downgrades, increased debt levels, litigation, provider contracting, and challenges in achieving synergies from acquisitions like the Trigon Healthcare, Inc. deal.

Does this filing provide specific financial performance numbers?

No, this 8-K filing itself does not contain the specific financial performance numbers. It serves as a notification that these results have been released in a press release, which is attached as an exhibit.

ELV 8-K SEC Disclosure — Apr 30, 2003

Summary

Elevance Health, Inc. (formerly Anthem, Inc.) filed an 8-K on April 30, 2003, to report its financial results for the first quarter ended March 31, 2003. This filing primarily serves as a notification of the release of this information, with the detailed financial results presented in an accompanying press release (Exhibit 99). Investors seeking specific financial performance metrics, such as revenue, earnings, and segment performance for the quarter, should refer to the referenced press release. The report also includes cautionary statements regarding forward-looking information. These statements, which are not historical facts, are subject to various risks and uncertainties that could cause actual results to differ materially from projections. These risks encompass industry-specific challenges like healthcare cost trends, regulatory changes, competitive pressures, and integration risks associated with past acquisitions, such as the Trigon Healthcare, Inc. acquisition. Investors are advised to review these disclosures carefully and consult other SEC filings for a comprehensive understanding of the company's financial condition and outlook.

Key Highlights

1Filing of an 8-K report by Anthem, Inc. on April 30, 2003.
2The report announces the release of first quarter financial results for the period ending March 31, 2003.
3Detailed financial results are provided in an attached press release (Exhibit 99).
4The filing includes standard safe harbor disclosures for forward-looking statements.
5Identifies potential risks and uncertainties affecting future financial performance.
6Mentions specific risks including healthcare cost trends, regulatory changes, and integration of the Trigon Healthcare acquisition.

Elevance Health, Inc. 8-K Report (Apr 30, 2003)

Summary

Key Highlights

Frequently Asked Questions